Jane Coates Ulrichsen

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 423 citations

Medicine, Immunology, Oncology +16

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

Geoffrey S. Williams, Sandrine Guillard, Jane Coates Ulrichsen et al. · Oncotarget · 2016 · 57 citations · Full text

Medicine, Immunology, Oncology +7

A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist

Rebecca Leyland, Amanda Watkins, Kathy Mulgrew et al. · Clinical Cancer Research · 2017 · 52 citations

Medicine, Oncology, Pharmacology +17

A qualitative study of the barriers to using blinding in in vivo experiments and suggestions for improvement

Natasha A. Karp, Esther J. Pearl, Emma J. Stringer et al. · PLoS Biology · 2022 · 26 citations · Full text

Public Health, Animal Sciences, Animal Welfare +16